Nonquantitative treatment limitations.

CA AB2011 aims to improve health care coverage by addressing nonquantitative treatment limitations, which are rules that restrict access to certain treatments without clear criteria. The bill requires health plans to provide more transparency and justification for these limitations, ensuring that patients receive fair access to necessary treatments. This legislation is intended to enhance patient rights and promote equitable health care services.

CA AB2011 is a house bill in the California 2025-2026 Regular Session, sponsored by Gregg Hart (D), currently “Passed” since September 30, 2026.

We track 5,060 California bills this session, 32 of them sponsored by Gregg Hart.

The key recorded vote (A, August 24, 2026) ended 61–13 and passed.

Supporters of CA AB2011 would highlight the bill as a significant step towards ensuring that all patients have equal access to necessary treatments, regardless of their health plan. They would frame it as a victory for patient rights, emphasizing the importance of transparency in health care decisions and the need for fair treatment options. This legislation is seen as a way to hold insurance companies accountable and improve overall health outcomes.

Critics of CA AB2011 may argue that the bill could lead to increased costs for health plans and insurance companies, potentially driving up premiums for consumers. They might express concerns that the added regulations could create administrative burdens that complicate health care delivery. Additionally, some may claim that the bill could inadvertently limit treatment options by imposing too many constraints on health care providers.

Source: LegiScan roll call vote data.